SCHEMBL4773415

SCHEMBL4773415

Cc1[nH]c2ccccc2c1CC(=O)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.43
KLK6 Q92876 1/20 0.42
NTRK1 P04629 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ADORA1 P30542 3/20 0.41
ADORA3 P0DMS8 2/20 0.41
CYP3A4 P08684 3/20 0.40
ADORA2B P29275 1/20 0.40
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
SYK P43405 1/20 0.39
IDE P14735 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP2C9 P11712 1/20 0.39
WNT3A P56704 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2238435 0.84 CYP3A4 (0.44) ALDH1A1MAPTCYP3A4CYP2C9ATM
SCHEMBL4776165 0.82 CCKBR (0.52) ALDH1A1MAPTCYP3A4KMT2ACYP2C9
SCHEMBL4769062 0.81 ADRB2 (0.46) ADORA2AKDM4EALDH1A1MAPTADORA1
SCHEMBL4773144 0.78 ADORA2A (0.47) ADORA2AKDM4EALDH1A1GAAMAPT
SCHEMBL4768684 0.77 ADORA2A (0.43) ADORA2AADORA1ADORA3CYP3A4ADORA2B
SCHEMBL4769102 0.77 KMT2A (0.55) ADORA2AALDH1A1GAAMAPTADORA1
SCHEMBL2239979 0.77 SPR (0.42) ALDH1A1CYP3A4CYP2C9ATM
SCHEMBL4768822 0.77 SMN1; SMN2 (0.60) ADORA2AKDM4EALDH1A1GAAMAPT
SCHEMBL4766014 0.77 ADORA1 (0.47) ADORA2AALDH1A1ADORA1ADORA3CYP3A4
SCHEMBL4770635 0.76 CYP1A2 (0.52) ADORA2AKDM4EALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed